Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol for prevention of COPD exacerbations
2017-002779-24Phase 3Unknown
- Sponsor
- University of Aberdeen
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Bisoprolol plus existing COPD treatment with Placebo plus existing COPD treatment (2 arms). Primary endpoint: Total number of COPD exacerbations requiring change in management during 1 year. Status: unknown.
02
Drugs
bisoprolol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2017-002779-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002779-24.